Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Compass Pathways

Clinical trials sponsored by Compass Pathways, explained in plain language.

Compass Pathways CMPS NASDAQ

Biotech company developing psilocybin-based therapies for mental health conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Magic mushroom compound takes on depression in major trial

Symptom relief Ongoing

This study tests a drug called COMP360 (a form of psilocybin, the active ingredient in magic mushrooms) in people with depression that hasn't improved with other treatments. About 572 adults will receive either a high or low dose, and researchers will measure changes in mood and …

Phase: PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief

Last updated Aug 12, 2026 00:00 UTC